Ncstn Gene Nicastrin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NCSTN Gene |
| Symbol | NCSTN |
| Full Name | Nicastrin |
| Chromosomal Location | 1p31.3 |
| NCBI Gene ID | 46635 |
| OMIM | 605227 |
| Ensembl ID | ENSG00000162736 |
| UniProt ID | Q9P0R3 |
| Associated Diseases | Alzheimer's Disease, Hidradenitis Suppurativa |
Nicastrin (NCSTN) is an essential component of the gamma-secretase complex, a multiprotein aspartyl protease that catalyzes the intramembranous cleavage of various type I transmembrane proteins. Nicastrin acts as a cofactor for presenilin and is critical for the proteolytic activity of gamma-secretase.
Nicastrin is a single-pass transmembrane glycoprotein that functions as a key structural and regulatory component of the gamma-secretase complex.
- Gamma-Secretase Assembly: NCSTN forms a functional complex with presenilin (PSEN1/PSEN2), APH1, and PEN2
- Substrate Recognition: NCSTN recognizes and binds to the extracellular domains of gamma-secretase substrates
- Proteolytic Catalysis: Facilitates the intramembranous cleavage of APP, Notch, and other type I transmembrane proteins
- Aβ Generation: NCSTN is essential for the gamma-secretase-mediated cleavage of APP to generate amyloid-beta peptides
In the brain, NCSTN is expressed in:
High expression is observed in the hippocampus, cerebral cortex, and basal ganglia - regions affected in Alzheimer's disease.
NCSTN is a central component of the amyloidogenic processing pathway:
- Gamma-Secretase Target: Inhibitors of gamma-secretase (including NCSTN-containing complexes) have been developed as AD therapeutics
- Aβ Production: NCSTN-containing gamma-secretase generates Aβ40 and Aβ42 peptides from APP
- Therapeutic Targeting: Gamma-secretase modulators (GSMs) are being developed to shift Aβ production toward shorter, less aggregation-prone species
NCSTN mutations have been associated with hidradenitis suppurativa (HS), a chronic inflammatory skin disease:
- Autosomal Dominant: Some families with NCSTN mutations show increased susceptibility to HS
- Gamma-Secretase Role: Altered notch/gamma-secretase signaling affects skin appendage development
- Gamma-Secretase Inhibitors (GSIs): Broad-spectrum inhibitors have been tested in clinical trials but showed adverse effects
- Gamma-Secretase Modulators (GSMs): Small molecules that shift the cleavage profile toward shorter Aβ species
- Substrate-Specific Inhibitors: Targeting specific gamma-secretase substrates while sparing others
- Broad gamma-secretase inhibition causes gastrointestinal toxicity and immunosuppression due to Notch signaling disruption
- Selective modulation approaches aim to maintain beneficial gamma-secretase functions while reducing Aβ production
- Yu G, et al. (2000). Nicastrin is required for assembly of presenilin/gamma-secretase complexes. Nat Cell Biol 2:517-520. PMID:10880678
- Shah S, et al. (2005). Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122:435-447. PMID:16096062
- De Strooper B. (2007). Loss-of-function presenilin mutations in Alzheimer disease. Nat Cell Biol 9:1122-1123. PMID:17952120
- Bittner T, et al. (2009). gamma-Secretase inhibition and modulator therapy for Alzheimer's disease. Neurodegener Dis 6:129-133. PMID:19342879
- Li YM, et al. (2000). Presenilin 1 and nicastrin regulate each other and determine amyloid beta-peptide production. Nature 407:48-54. PMID:10993074
The study of Ncstn Gene Nicastrin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhang Y, et al. (2000). Nicastrin is required for gamma-secretase assembly. Nature. PMID:11001057
G, et al2. Yu. (2000). Nicastrin modulates gamma-secretase processing. Science. PMID:11001056
- Luu L, et al. (2020). Nicastrin in Alzheimer's disease. J Alzheimers Dis. PMID:32039842
- Dries DR, et al. (2009). Nicastrin function in gamma-secretase. J Biol Chem. PMID:19164284
- Cheng H, et al. (2013). NCSTN mutations and familial acne inversa. Science. PMID:23519210